|
Singular Genomics Systems Inc (NASDAQ: OMIC) |
|
Singular Genomics Systems Inc
OMIC's Fundamental analysis
Select the Comparisons :
|
|
Select the Ratio:
|
|
|
Singular Genomics Systems Inc 's sales fell
by -12.12 % in III. Quarter 2024 from the same quarter a year ago.
Ranking at No. 906
Laboratory Analytical Instruments industry recorded
growth of revenues by 1.41 %
Singular Genomics Systems Inc net loss decreased from $-22 millions, to $-17 millions in III. Quarter 2024,
• More on OMIC's Growth
|
|
Singular Genomics Systems Inc realized a net loss in trailing twelve months.
Company is currently trading with Price to Cash flow multiple of 2.73 in trailing twelve-month period. Laboratory Analytical Instruments industry recorded net loss in trailing twelve months. |
Company |
- |
PE TTM
|
Industry |
10.56 |
PE TTM
|
|
Company's Price to Sales ratio is at 18.65.
Laboratory Analytical Instruments industry's Price to Sales ratio is at 5.75.
• More on OMIC's Valuation
|
|
|
|
|
Singular Genomics Systems Inc realized net loss in trailing twelve months.
Company is currently trading with Price to Cash flow multiple of 2.73 in trailing twelve-month period. Laboratory Analytical Instruments industry recorded net loss in trailing twelve months. |
Company |
- |
PE TTM
|
Industry |
10.56 |
PE TTM
|
|
Company's Price to Sales ratio is at 18.65.
Laboratory Analytical Instruments industry's Price to Sales ratio is at 5.75.
Singular Genomics Systems Inc Price to Book Ratio is at 0.4 lower than Industry Avg. of 307.11. and higher than S&P 500 Avg. of 0.01
• More on OMIC's Valuation
|
|
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2025 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com